The total return over the past 12 months is +6.13% vs. +16.94% for the S&P 500. So far it's up -23.38% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +6.13% | (14.50%) | (15.23%) | N/A | N/A | N/A |
| Total Return CAGR | +6.13% | (14.50%) | (15.23%) | N/A | N/A | N/A |
| Revenue CAGR | +62.18% | +33.58% | +16.55% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Profound Medical Corp. (PROF)
| Year | Start price | End price | PROF Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $7.87 | $6.03 | (23.38%) | +14.51% | (37.89%) |
| 2025 | $7.51 | $7.87 | +4.79% | +17.72% | (12.93%) |
| 2024 | $8.49 | $7.51 | (11.54%) | +24.89% | (36.43%) |
| 2023 | $10.89 | $8.49 | (22.04%) | +26.19% | (48.23%) |
| 2022 | $11.23 | $10.89 | (3.03%) | (18.17%) | +15.14% |
| 2021 | $20.56 | $11.23 | (45.38%) | +28.74% | (74.12%) |
| 2020 | $10.95 | $20.56 | +87.76% | +18.37% | +69.39% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
